XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long Term Debt - Additional Information (Detail) - USD ($)
$ in Millions
1 Months Ended
Jan. 01, 2023
May 09, 2022
May 01, 2022
May 31, 2022
Sep. 30, 2022
Debt instrument, Face amount         $ 50.0
Interest rate         10.20%
Percenatge of Term charges on aggregate principal amount       5.35%  
Debt conversion, converted instrument, warrants or options issued     14,899    
Debt conversion, converted instrument, amount   $ 0.6      
Loan Facility [Member] | Subsequent Event [Member]          
Line of credit facility, maximum borrowing capacity $ 35.0        
Line of credit facility, expiration date Sep. 30, 2024        
Drawn In Two Separate Tranches Upon AchievementOf Resmetirom Clinical And Regulatory Milestone s [Member]          
Unused borrowing capacity that can be drawn       $ 125.0  
Term Loan          
Debt instrument, Face amount       250.0  
Proceeds from issuance of debt       $ 50.0  
Long term debt floor interest rate percentage       7.45%  
Debt Instrument Interest Payments Terms       The Company will pay interest-only monthly payments of accrued interest under the Loan Facility for a period of 30 months, which period may be extended to 36, 48, and 60 months upon the successive achievement of certain clinical and regulatory milestones  
Term Loan | Drawn In Two Separate Tranches Upon AchievementOf Resmetirom Clinical And Regulatory Milestone s [Member]          
Unused borrowing capacity that can be drawn       $ 75.0